Family Indicates Man Committed Suicide Because of Propecia

An emergency room doctor alleges that his son committed suicide because of Propecia side effects, after he was left impotent by Merck’s medication for treatment of male hair loss.

Dr. John Santmann joined a protest over Propecia last month outside of Merck & Co.’s New Jersey headquarters, which was designed to bring attention to the company’s inaction in addressing problems with Propecia, which could include permanent erectile dysfunction, loss of libido and depression.

Randy Santmann killed himself in 2008, at the age of 22, after taking Propecia for three years and developing sexual problems from the medication that continued at least six months after he stopped using the drug, according to his family.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Propecia (finasteride) is a prescription medication approved to help restore natural hair loss that occurs in some men. While the warning label has indicated that some men developed erectile dysfunction and other sexual side effects, until recently, the drug maker suggested that such problems resolve when the medication is no longer used.

Although Merck updated the warnings provided in several other countries to indicate that some men reported suffering persistent sexual side effects from Propecia after the hair-loss drug was no longer used, they resisted updating the warnings provided in the United States until April 2012.

A number of men throughout the United States are now pursuing a Propecia lawsuit against Merck for failing to adequately warn about the risks associated with the medication.  Many plaintiffs allege that if they had been provided with accurate information about the risk of long-term sexual dysfunction, they never would have taken the prescription drug to help restore hair loss and improve their appearance.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Lawyers Propose MDL Trial Dates for Baby Formula NEC Lawsuit Starting in May 2025
Lawyers Propose MDL Trial Dates for Baby Formula NEC Lawsuit Starting in May 2025 (Posted yesterday)

A series of four bellwether claims in the baby formula NEC lawsuit MDL will be ready to go before a federal juries in May 2025, August 2025, November 2025 and February 2026 according to a proposed trial schedule agreed upon by both plaintiffs and defendants.

AngioDynamics Port Catheter Lawsuit MDL Established in Southern District of California
AngioDynamics Port Catheter Lawsuit MDL Established in Southern District of California (Posted 2 days ago)

U.S. JPML has transferred all AngioDynamics port catheter lawsuits to the U.S. District Court for the Southern District of California, for coordinated discovery and pretrial proceedings as part of a federal MDL (multidistrict litigation).